Merck & Co Inc
NYSE: MRK
$99.25
-$0.60 (-0.6%)
Closing Price on January 10, 2025
MRK Articles
September 20, 2016: Markets opened higher Tuesday as no sector was showing big gains but healthcare stocks the clear leader. Traders and investors are likely trying to position themselves for the...
Published:
Last Updated:
September 19, 2016: Markets opened higher Monday and while most sectors traded in the green the gains didn’t add up to much. Fresh speculation about an OPEC production freeze pushed oil prices up...
Published:
Last Updated:
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
September 7, 2016: Markets opened mixed Wednesday following largely unmemorable sessions overseas. European markets await a policy statement from the ECB due Thursday morning. The Beige Book’s...
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Published:
Last Updated:
August 24, 2016: Markets opened lower Wednesday and only the Nasdaq Composite made even a brief visit to positive territory during the day’s trading session. Healthcare and materials stocks led the...
Published:
Last Updated:
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, nor do we know what price.
Published:
Last Updated:
Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for each of its large cap pharmaceutical stocks.
Published:
Last Updated:
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
Published:
Last Updated:
The short interest data for the July 29 settlement date are out and it almost feels like short sellers are getting a bit panicked about the market rally.
Published:
Last Updated:
August 9, 2016: Markets opened higher again Tuesday following the lead of Asian and European exchanges. The productivity report cooled investors’ enthusiasm, though, and afternoon trading saw...
Published:
Last Updated:
August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red for the rest of the day. The dollar gained strength this afternoon and crude oil...
Published:
Last Updated:
Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise estimates for Bristol-Myers.
Published:
Last Updated:
August 5, 2016: Markets opened higher Friday following the report of 255,000 new U.S. jobs added in July. The financial and tech sectors led the gainers today, the former likely on improved chances...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.